Jane Street’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $153K | Buy |
+70,931
| New | +$153K | ﹤0.01% | 4865 |
|
|
2024
Q3 | – | Sell |
-29,202
| Closed | -$200K | – | 5882 |
|
|
2024
Q2 | $200K | Buy |
+29,202
| New | +$200K | ﹤0.01% | 5393 |
|
|
2023
Q4 | – | Sell |
-3,388
| Closed | -$50.8K | – | 5691 |
|
|
2023
Q3 | $50.8K | Sell |
3,388
-1,275
| -27% | -$19.1K | ﹤0.01% | 4764 |
|
|
2023
Q2 | $74.1K | Sell |
4,663
-4,601
| -50% | -$73.2K | ﹤0.01% | 4875 |
|
|
2023
Q1 | $66.5K | Buy |
9,264
+2,348
| +34% | +$16.8K | ﹤0.01% | 5052 |
|
|
2022
Q4 | $40.1K | Buy |
6,916
+5,534
| +400% | +$32.1K | ﹤0.01% | 4930 |
|
|
2022
Q3 | $13K | Buy |
+1,382
| New | +$13K | ﹤0.01% | 5386 |
|
|
2022
Q1 | – | Sell |
-4,866
| Closed | -$86K | – | 5580 |
|
|
2021
Q4 | $86K | Buy |
4,866
+3,662
| +304% | +$64.7K | ﹤0.01% | 4718 |
|
|
2021
Q3 | $26K | Buy |
+1,204
| New | +$26K | ﹤0.01% | 5023 |
|
|
2021
Q2 | – | Sell |
-4,206
| Closed | -$415K | – | 5110 |
|
|
2021
Q1 | $415K | Sell |
4,206
-1,172
| -22% | -$116K | ﹤0.01% | 3548 |
|
|
2020
Q4 | $583K | Sell |
5,378
-2,023
| -27% | -$219K | ﹤0.01% | 2614 |
|
|
2020
Q3 | $762K | Buy |
7,401
+154
| +2% | +$15.9K | ﹤0.01% | 2039 |
|
|
2020
Q2 | $1.51M | Buy |
7,247
+5,663
| +358% | +$1.18M | ﹤0.01% | 1571 |
|
|
2020
Q1 | $155K | Sell |
1,584
-560
| -26% | -$54.8K | ﹤0.01% | 2978 |
|
|
2019
Q4 | $247K | Sell |
2,144
-1,929
| -47% | -$222K | ﹤0.01% | 2850 |
|
|
2019
Q3 | $222K | Buy |
+4,073
| New | +$222K | ﹤0.01% | 2970 |
|
|
2018
Q2 | – | Sell |
-1,011
| Closed | -$59K | – | 3200 |
|
|
2018
Q1 | $59K | Buy |
+1,011
| New | +$59K | ﹤0.01% | 2975 |
|
|
2017
Q4 | – | Sell |
-2,967
| Closed | -$108K | – | 3015 |
|
|
2017
Q3 | $108K | Buy |
+2,967
| New | +$108K | ﹤0.01% | 2726 |
|